(National Catholic Register. Matthew McDonald).
The limited abortion-pill decision of the U.S. Supreme Court June 13 leaves major questions about the future of the drug unanswered, pro-life advocates contend. The high court unanimously found in Food and Drug Administration v. Alliance for Hippocratic Medicine that the four pro-life organizations and four pro-life doctors who brought a lawsuit challenging loosened federal regulations on abortion pills lacked standing — meaning they aren’t, in the court’s view, affected enough by the federal agency’s decisions to bring the lawsuit. But the court did not rule on the merits of their case. About 63% of all abortions in the United States in 2023 took place through abortion pills, according to the Guttmacher Institute, which supports abortion and collects information about it. That percentage has been steadily growing in recent years and is expected to keep rising. This means that abortion policy is quickly becoming abortion-pill policy.
Here are four abortion pill issues that are still unresolved: